Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with Bupivacaine for Pediatric Caudal Analgesia
NCT02385435Phase 3Completed
- Sponsor
- University of Jordan
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by University of Jordan. Primary endpoints: Time to first analgesic requirement at 24 hours, Postoperative pain scores at 24 hours and 1 more. Started Jan 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02385435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02385435.